US Stock MarketDetailed Quotes

LH Labcorp Holdings

Watchlist
  • 241.290
  • +1.620+0.68%
Close Nov 25 16:00 ET
  • 241.290
  • 0.0000.00%
Post 16:44 ET
20.18BMarket Cap45.79P/E (TTM)

Labcorp Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
0.65%277.3M
247.43%561.1M
-116.05%-29.8M
-31.87%1.2B
-4.55%579.6M
8.89%275.5M
-70.56%161.5M
-47.84%185.7M
-38.00%1.76B
39.84%607.2M
Net income from continuing operations
-7.63%169.6M
32.47%205.6M
9.55%228.3M
-62.09%380.4M
-549.60%-166.8M
-33.79%183.6M
-21.22%155.2M
-57.65%208.4M
-54.34%1B
-90.02%37.1M
Depreciation and amortization
10.69%161.5M
9.80%156.9M
8.73%154.5M
7.46%577.3M
12.27%146.4M
8.80%145.9M
28.51%142.9M
-12.01%142.1M
-6.90%537.2M
555.28%130.4M
Deferred tax
43.31%-19.5M
-78.18%-19.6M
-171.69%-19.5M
-396.96%-78.1M
-184.25%-59.9M
-64.59%-34.4M
-124.49%-11M
243.16%27.2M
170.51%26.3M
9.89%71.1M
Other non cash items
30.09%57.5M
120.73%84.1M
-17.96%41.1M
5.83%206.9M
12.03%74.5M
64.31%44.2M
-32.92%38.1M
10.60%50.1M
50.50%195.5M
159.77%66.5M
Change In working capital
-9.59%-118.8M
151.42%103.3M
-68.94%-468.3M
3.80%-361.9M
1,147.78%224.6M
44.09%-108.4M
-223.25%-200.9M
23.70%-277.2M
-144.60%-376.2M
126.09%18M
-Change in receivables
222.62%45M
-334.44%-42.2M
-139.22%-123.2M
-425.97%-75.3M
-118.28%-5.1M
-400.82%-36.7M
-61.78%18M
19.66%-51.5M
-89.79%23.1M
-89.91%27.9M
-Change in inventory
-199.61%-25.7M
563.93%28.3M
94.00%-600K
98.46%-700K
-620.00%-10.4M
318.64%25.8M
-458.82%-6.1M
73.26%-10M
-1,725.00%-45.5M
-78.49%2M
-Change in prepaid assets
-37.36%-61.4M
70.33%46.5M
56.70%-24.9M
89.43%-25.8M
125.65%49.1M
-26.99%-44.7M
15.68%27.3M
-39.90%-57.5M
-488.19%-244.1M
-719.42%-191.4M
-Change in payables and accrued expense
-15.87%-79.6M
123.16%59.9M
-59.31%-278M
-105.97%-365.6M
-2.23%136.2M
56.27%-68.7M
-545.09%-258.6M
19.88%-174.5M
48.58%-177.5M
145.55%139.3M
-Change in other working capital
-81.76%2.9M
-41.62%10.8M
-355.21%-41.6M
55.60%105.5M
36.32%54.8M
895.00%15.9M
-43.08%18.5M
662.07%16.3M
1,684.21%67.8M
150.25%40.2M
Cash from discontinued investing activities
0
0
0
-34.38%125.4M
0
0
189.9M
-64.5M
-27.42%191.1M
46.4M
Operating cash flow
0.65%277.3M
59.68%561.1M
-124.59%-29.8M
-32.12%1.33B
-11.32%579.6M
-26.30%275.5M
-38.62%351.4M
-65.96%121.2M
-37.10%1.96B
-6.29%653.6M
Investing cash flow
Cash flow from continuing investing activities
-18.77%-579.1M
24.37%-185M
-367.98%-393.1M
28.31%-1.15B
-29.90%-330.6M
10.14%-487.6M
-6.63%-244.6M
85.34%-84M
-89.15%-1.6B
-18.04%-254.5M
Capital expenditure reported
-10.39%-115.8M
-24.10%-128.2M
-71.10%-133.8M
-5.66%-453.6M
-68.72%-167.2M
-26.69%-104.9M
20.66%-103.3M
33.28%-78.2M
-1.85%-429.3M
10.80%-99.1M
Net business purchase and sale
-19.05%-463.7M
59.76%-56.9M
-4,296.61%-259.4M
42.23%-671.5M
5.61%-134.7M
15.34%-389.5M
-38.22%-141.4M
98.71%-5.9M
-133.93%-1.16B
12.61%-142.7M
Net investment purchase and sale
----
----
----
-139.78%-22.3M
-124.81%-29M
----
----
----
36.30%-9.3M
48.40%-12.9M
Net other investing changes
300.00%400K
0.00%100K
0.00%100K
-57.14%600K
50.00%300K
0.00%100K
0.00%100K
-90.00%100K
-98.40%1.4M
-99.76%200K
Cash from discontinued investing activities
Investing cash flow
-18.77%-579.1M
27.05%-185M
-294.28%-393.1M
29.09%-1.17B
-20.97%-330.6M
13.44%-487.6M
-4.58%-253.6M
82.60%-99.7M
-86.77%-1.65B
-7.39%-273.3M
Financing cash flow
Cash flow from continuing financing activities
256.74%1.55B
-227.61%-210M
80.69%-11.7M
-17.91%-1.56B
-19.83%-446.5M
-118.44%-987.8M
86.64%-64.1M
-242.37%-60.6M
36.00%-1.32B
63.06%-372.6M
Net issuance payments of debt
1,440.40%1.38B
---22.6M
--42.4M
---300M
---389.6M
--89.6M
--0
--0
--0
--0
Net common stock issuance
92.57%-75M
----
----
9.09%-1B
103.00%9M
-152.25%-1.01B
----
----
34.07%-1.1B
70.00%-300M
Cash dividends paid
5.32%-60.5M
6.50%-60.4M
3.57%-62.1M
-30.12%-254M
3.93%-61.1M
1.54%-63.9M
3.15%-64.6M
---64.4M
---195.2M
---63.6M
Proceeds from stock option exercised by employees
--26.3M
--0
-3.26%26.7M
7.51%54.4M
--0
--0
2,877.78%26.8M
51.65%27.6M
-2.13%50.6M
--0
Net other financing activities
6,262.22%277.3M
-2.66%-27M
21.43%-18.7M
23.45%-59.4M
46.67%-4.8M
76.06%-4.5M
-89.21%-26.3M
33.70%-23.8M
-4.86%-77.6M
5.26%-9M
Cash from discontinued financing activities
0
0
0
1.5B
0
-109.4M
1.61B
0
0
0
Financing cash flow
241.11%1.55B
-113.59%-210M
80.69%-11.7M
95.52%-59.3M
-19.83%-446.5M
-142.64%-1.1B
422.08%1.55B
-242.37%-60.6M
36.00%-1.32B
63.06%-372.6M
Net cash flow
Beginning cash position
-86.27%265.1M
-66.32%99.3M
24.84%536.8M
-70.80%430M
138.73%727.9M
97.34%1.93B
-76.10%294.8M
-70.80%430M
11.50%1.47B
-85.03%304.9M
Current changes in cash
203.88%1.25B
-89.83%166.1M
-214.47%-434.6M
108.59%96.9M
-94.20%-197.5M
-86.99%-1.2B
1,190.51%1.63B
41.14%-138.2M
-1,761.12%-1.13B
84.52%-101.7M
Effect of exchange rate changes
303.57%5.7M
-109.09%-300K
-196.67%-2.9M
140.91%9.9M
-48.39%6.4M
83.72%-2.8M
122.00%3.3M
168.18%3M
-231.51%-24.2M
588.89%12.4M
End cash Position
108.45%1.52B
-86.27%265.1M
-66.32%99.3M
67.44%536.8M
67.44%536.8M
138.73%727.9M
97.34%1.93B
-76.10%294.8M
-76.79%320.6M
-76.79%320.6M
Free cash flow
-5.33%161.5M
74.49%432.9M
-480.47%-163.6M
-42.74%874.1M
-25.63%412.4M
-41.37%170.6M
-43.91%248.1M
-81.99%43M
-43.21%1.53B
-5.44%554.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 0.65%277.3M247.43%561.1M-116.05%-29.8M-31.87%1.2B-4.55%579.6M8.89%275.5M-70.56%161.5M-47.84%185.7M-38.00%1.76B39.84%607.2M
Net income from continuing operations -7.63%169.6M32.47%205.6M9.55%228.3M-62.09%380.4M-549.60%-166.8M-33.79%183.6M-21.22%155.2M-57.65%208.4M-54.34%1B-90.02%37.1M
Depreciation and amortization 10.69%161.5M9.80%156.9M8.73%154.5M7.46%577.3M12.27%146.4M8.80%145.9M28.51%142.9M-12.01%142.1M-6.90%537.2M555.28%130.4M
Deferred tax 43.31%-19.5M-78.18%-19.6M-171.69%-19.5M-396.96%-78.1M-184.25%-59.9M-64.59%-34.4M-124.49%-11M243.16%27.2M170.51%26.3M9.89%71.1M
Other non cash items 30.09%57.5M120.73%84.1M-17.96%41.1M5.83%206.9M12.03%74.5M64.31%44.2M-32.92%38.1M10.60%50.1M50.50%195.5M159.77%66.5M
Change In working capital -9.59%-118.8M151.42%103.3M-68.94%-468.3M3.80%-361.9M1,147.78%224.6M44.09%-108.4M-223.25%-200.9M23.70%-277.2M-144.60%-376.2M126.09%18M
-Change in receivables 222.62%45M-334.44%-42.2M-139.22%-123.2M-425.97%-75.3M-118.28%-5.1M-400.82%-36.7M-61.78%18M19.66%-51.5M-89.79%23.1M-89.91%27.9M
-Change in inventory -199.61%-25.7M563.93%28.3M94.00%-600K98.46%-700K-620.00%-10.4M318.64%25.8M-458.82%-6.1M73.26%-10M-1,725.00%-45.5M-78.49%2M
-Change in prepaid assets -37.36%-61.4M70.33%46.5M56.70%-24.9M89.43%-25.8M125.65%49.1M-26.99%-44.7M15.68%27.3M-39.90%-57.5M-488.19%-244.1M-719.42%-191.4M
-Change in payables and accrued expense -15.87%-79.6M123.16%59.9M-59.31%-278M-105.97%-365.6M-2.23%136.2M56.27%-68.7M-545.09%-258.6M19.88%-174.5M48.58%-177.5M145.55%139.3M
-Change in other working capital -81.76%2.9M-41.62%10.8M-355.21%-41.6M55.60%105.5M36.32%54.8M895.00%15.9M-43.08%18.5M662.07%16.3M1,684.21%67.8M150.25%40.2M
Cash from discontinued investing activities 000-34.38%125.4M00189.9M-64.5M-27.42%191.1M46.4M
Operating cash flow 0.65%277.3M59.68%561.1M-124.59%-29.8M-32.12%1.33B-11.32%579.6M-26.30%275.5M-38.62%351.4M-65.96%121.2M-37.10%1.96B-6.29%653.6M
Investing cash flow
Cash flow from continuing investing activities -18.77%-579.1M24.37%-185M-367.98%-393.1M28.31%-1.15B-29.90%-330.6M10.14%-487.6M-6.63%-244.6M85.34%-84M-89.15%-1.6B-18.04%-254.5M
Capital expenditure reported -10.39%-115.8M-24.10%-128.2M-71.10%-133.8M-5.66%-453.6M-68.72%-167.2M-26.69%-104.9M20.66%-103.3M33.28%-78.2M-1.85%-429.3M10.80%-99.1M
Net business purchase and sale -19.05%-463.7M59.76%-56.9M-4,296.61%-259.4M42.23%-671.5M5.61%-134.7M15.34%-389.5M-38.22%-141.4M98.71%-5.9M-133.93%-1.16B12.61%-142.7M
Net investment purchase and sale -------------139.78%-22.3M-124.81%-29M------------36.30%-9.3M48.40%-12.9M
Net other investing changes 300.00%400K0.00%100K0.00%100K-57.14%600K50.00%300K0.00%100K0.00%100K-90.00%100K-98.40%1.4M-99.76%200K
Cash from discontinued investing activities
Investing cash flow -18.77%-579.1M27.05%-185M-294.28%-393.1M29.09%-1.17B-20.97%-330.6M13.44%-487.6M-4.58%-253.6M82.60%-99.7M-86.77%-1.65B-7.39%-273.3M
Financing cash flow
Cash flow from continuing financing activities 256.74%1.55B-227.61%-210M80.69%-11.7M-17.91%-1.56B-19.83%-446.5M-118.44%-987.8M86.64%-64.1M-242.37%-60.6M36.00%-1.32B63.06%-372.6M
Net issuance payments of debt 1,440.40%1.38B---22.6M--42.4M---300M---389.6M--89.6M--0--0--0--0
Net common stock issuance 92.57%-75M--------9.09%-1B103.00%9M-152.25%-1.01B--------34.07%-1.1B70.00%-300M
Cash dividends paid 5.32%-60.5M6.50%-60.4M3.57%-62.1M-30.12%-254M3.93%-61.1M1.54%-63.9M3.15%-64.6M---64.4M---195.2M---63.6M
Proceeds from stock option exercised by employees --26.3M--0-3.26%26.7M7.51%54.4M--0--02,877.78%26.8M51.65%27.6M-2.13%50.6M--0
Net other financing activities 6,262.22%277.3M-2.66%-27M21.43%-18.7M23.45%-59.4M46.67%-4.8M76.06%-4.5M-89.21%-26.3M33.70%-23.8M-4.86%-77.6M5.26%-9M
Cash from discontinued financing activities 0001.5B0-109.4M1.61B000
Financing cash flow 241.11%1.55B-113.59%-210M80.69%-11.7M95.52%-59.3M-19.83%-446.5M-142.64%-1.1B422.08%1.55B-242.37%-60.6M36.00%-1.32B63.06%-372.6M
Net cash flow
Beginning cash position -86.27%265.1M-66.32%99.3M24.84%536.8M-70.80%430M138.73%727.9M97.34%1.93B-76.10%294.8M-70.80%430M11.50%1.47B-85.03%304.9M
Current changes in cash 203.88%1.25B-89.83%166.1M-214.47%-434.6M108.59%96.9M-94.20%-197.5M-86.99%-1.2B1,190.51%1.63B41.14%-138.2M-1,761.12%-1.13B84.52%-101.7M
Effect of exchange rate changes 303.57%5.7M-109.09%-300K-196.67%-2.9M140.91%9.9M-48.39%6.4M83.72%-2.8M122.00%3.3M168.18%3M-231.51%-24.2M588.89%12.4M
End cash Position 108.45%1.52B-86.27%265.1M-66.32%99.3M67.44%536.8M67.44%536.8M138.73%727.9M97.34%1.93B-76.10%294.8M-76.79%320.6M-76.79%320.6M
Free cash flow -5.33%161.5M74.49%432.9M-480.47%-163.6M-42.74%874.1M-25.63%412.4M-41.37%170.6M-43.91%248.1M-81.99%43M-43.21%1.53B-5.44%554.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Infectious Disease
Infectious Disease
Intraday+0.89%
CRO
CRO
Intraday+0.84%